US Brand Name – Revlimid
Brand Name – Lenalid
Content Name- Lenalidomid
Manufacturer – Natco
Strength – 25mg
Form – Capsules
- Revlimid Capsules
- Additional information
- Product Enquiry
- Reviews (0)
Revlimid capsules is used to treat anemia (low red blood cells) in patients with a certain type of myelodysplastic syndrome. Revlimid capsules is also used in combination with dexamethasone to treat multiple myeloma (plasma cell cancer).
REVLIMID, a thalidomide analogue, is an immunomodulatory agent with antiangiogenic and antineoplastic properties.Each capsule contains lenalidomid as the active ingredient and the following inactive ingredients: lactose anhydrous, microcrystalline cellulose, croscarmellose sodium, and magnesium stearate.
Enquiry about Revlimid Capsules
In what manner would it be advisable for me to take REVLIMID?
Take REVLIMID precisely as recommended and adhere to every one of the directions of the REVLIMID REMS program
Gulp down REVLIMID containers with water 1 time multi day. Try not to open, break, or bite your containers.
REVLIMID might be taken with or without sustenance.
Take REVLIMID at about a similar time every day.
Try not to open the REVLIMID containers or handle them any more than required. In the event that you contact a broken REVLIMID container or the drug in the case, wash the zone of your body immediately with cleanser and water.
On the off chance that you miss a portion of REVLIMID and it has been under 12 hours since your normal time, accept it when you recall. On the off chance that it has been over 12 hours, simply avoid your missed portion. Try not to take 2 portions in the meantime.
In the event that you take excessively REVLIMID, summon your medicinal services supplier right.
Try not to impart REVLIMID to other individuals. It might cause birth surrenders and different difficult issues.
Lenalidomide (exchange name Revlimid) is a subsidiary of thalidomide affirmed in the United States in 2005.
It was at first proposed as a treatment for various myeloma, for which thalidomide is an acknowledged helpful treatment. Lenalidomide has likewise demonstrated viability in the class of hematological issue known as myelodysplastic disorders (MDS). Alongside a few different medications created as of late, lenalidomide has essentially enhanced generally speaking survival in myeloma (which earlier conveyed a poor guess), in spite of the fact that danger remains an issue for users. It costs $163,381 every year for the normal patient.